Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00352
Species: Homo sapiens
Position : chr13:28840000-28850000
Year: 2023
Title: Systematic characterization of the HOXA9 downstream targets in MLL-r leukemia by noncoding CRISPR screens
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: B-cell acute lymphoblastic leukemia
PMID:  38016946
MONDO: MONDO:0004945
Tissue: Bone Marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: SEM
CVCL ID: CVCL_0095
Cell Type: B lymphoblast
Cell Ontology ID: CL:0000945
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq, Hi-C, ATAC-seq, Capture-C
Low Throughput Method: CRISPR Knockout, CRISPRi, qRT-PCR, Western blot, Competitive Proliferation Assay, Flow Cytometry, In Vivo Transplantation Assay
About Target Gene
Target gene : GFI1
About TF
TF name : HOXA9
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
HOXA9 TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00392 chr13:28843000-28843500 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
E_00393 chr13:28843000-28843500 Blood B lymphoblastoid cell --
E_00394 chr13:28843000-28843500 Bone Marrow B lymphoblast B-cell acute lymphoblastic leukemia
Expression of Target Genes for the Enhancer